Evaluation of Serologic Changes of IgG and IgM Antibodies Associated with SARS-COV-2 in Cancer Patients: A Cohort Seroprevalence Study

BACKGROUND: While the coronavirus disease 2019 (COVID-19) pandemic spreads, there is increasing evidence to suggest the elevated risk of SARS-CoV-2 infection and following morbidity and mortality in cancer patients. Serology testing using ELISA proposes major advantages as a diagnostic and preventiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Arab, Maliheh, Noei Teymoordash, Somayyeh, Talayeh, Maryam, Ghavami, Behnaz, Javadi, Abdolreza, Nouri, Behnaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418854/
https://www.ncbi.nlm.nih.gov/pubmed/34181320
http://dx.doi.org/10.31557/APJCP.2021.22.6.1667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418854/
https://www.ncbi.nlm.nih.gov/pubmed/34181320
http://dx.doi.org/10.31557/APJCP.2021.22.6.1667

Ejemplares similares